Tapewire

Nasdaq · USD

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Export transactions ↓
Tapewire entity
5650
SEC CIK
0001299130
Parsed reports
244

Last 12 months

Inside the activity.

0 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202606
Mar 202603
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionStock Option (right to buy) · Derivative 45,686 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · derivative · entry 26

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,314

Underlying: Common Stock · 45,686 shares

Expires 2027-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionStock Option (right to buy) · Derivative 45,967 $0.00 Strike: $7.87 $0.00
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · derivative · entry 25

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,033

Underlying: Common Stock · 45,967 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionStock Option (right to buy) · Derivative 45,890 $0.00 Strike: $5.72 $0.00
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · derivative · entry 24

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,110

Underlying: Common Stock · 45,890 shares

Expires 2025-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionStock Option (right to buy) · Derivative 45,689 $0.00 Strike: $6.14 $0.00
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · derivative · entry 23

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,811

Underlying: Common Stock · 45,689 shares

Expires 2024-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC SaleCommon Stock 42,114 $41.06 $1,729,369.30
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 10

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 848,405

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.

F6 · price: This sale price represents the weighted average sale price of the shares sold ranging from $40.67 to $41.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC SaleCommon Stock 57,902 $40.28 $2,332,524.17
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 9

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 890,519

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.

F5 · price: This sale price represents the weighted average sale price of the shares sold ranging from $39.67 to $40.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC SaleCommon Stock 38,360 $39.15 $1,501,640.56
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 8

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 948,421

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.

F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $38.67 to $39.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC SaleCommon Stock 33,491 $38.08 $1,275,404.26
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 7

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 986,781

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.

F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $37.65 to $38.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC SaleCommon Stock 57,260 $37.17 $2,128,468.72
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 6

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,020,272

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $36.65 to $37.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionCommon Stock 45,895 $2.63 $120,703.85
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 5

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,077,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionCommon Stock 45,686 $5.27 $240,765.22
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 4

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,031,637

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionCommon Stock 45,967 $7.87 $361,760.29
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 3

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 985,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionCommon Stock 45,890 $5.72 $262,490.80
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 2

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 939,984

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 25, 2021 01:50 UTC Exercise / conversionCommon Stock 45,689 $6.14 $280,530.46
Disclosure

SEC source: 0001299130-21-000087 · certent-form4.xml · nonDerivative · entry 1

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 894,094

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:48 UTC
Schaefer EricChief Accounting Officer
GrantStock Option (right to buy) · Derivative 10,100 $0.00 Strike: $46.37 $0.00
Disclosure

SEC source: 0001299130-21-000069 · certent-form4.xml · derivative · entry 2

Schaefer Eric · CIK 0001813942 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,100

Underlying: Common Stock · 10,100 shares

Expires 2031-02-16

F3 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:48 UTC
Schaefer EricChief Accounting Officer
GrantCommon Stock 5,050 $0.00 $0.00
Disclosure

SEC source: 0001299130-21-000069 · certent-form4.xml · nonDerivative · entry 1

Schaefer Eric · CIK 0001813942 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,316

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 16 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date.

F2 · balance_after: Includes 7,267 shares acquired under the Issuer's Employee Stock Purchase Plan on September 1, 2020.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 50,394 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 15

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,106

Underlying: Common Stock · 50,394 shares

Expires 2028-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installment, over a four year period

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,485 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 14

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,515

Underlying: Common Stock · 25,485 shares

Expires 2027-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installment, over a four year period

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 13

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $8.98 $0.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 12

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2026-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $5.79 $0.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 11

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2025-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 35,000 $0.00 Strike: $6.98 $0.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 10

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,000 shares

Expires 2024-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC SaleCommon Stock 1,100 $49.00 $53,900.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 9

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,875

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC SaleCommon Stock 101,004 $48.47 $4,895,259.86
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 8

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,975

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC SaleCommon Stock 118,667 $47.58 $5,646,650.53
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 7

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,979

F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $47.00 to $47.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionCommon Stock 50,394 $2.63 $132,536.22
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 6

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionCommon Stock 25,485 $2.90 $73,906.50
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 5

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionCommon Stock 25,000 $3.81 $95,250.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 4

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionCommon Stock 25,000 $8.98 $224,500.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 3

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionCommon Stock 25,000 $5.79 $144,750.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 2

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:52 UTC Exercise / conversionCommon Stock 35,000 $6.98 $244,300.00
Disclosure

SEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 1

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:42 UTC
HENRY CHRISTIAN OPresident & CEO
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $46.37 $0.00
Disclosure

SEC source: 0001299130-21-000066 · certent-form4.xml · derivative · entry 2

HENRY CHRISTIAN O · CIK 0001263805 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-02-16

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:42 UTC
HENRY CHRISTIAN OPresident & CEO
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001299130-21-000066 · certent-form4.xml · nonDerivative · entry 1

HENRY CHRISTIAN O · CIK 0001263805 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 765,000

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 16 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:40 UTC
Kim Susan G.Chief Financial Officer
GrantStock Option (right to buy) · Derivative 12,600 $0.00 Strike: $46.37 $0.00
Disclosure

SEC source: 0001299130-21-000064 · certent-form4.xml · derivative · entry 2

Kim Susan G. · CIK 0001825421 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,600

Underlying: Common Stock · 12,600 shares

Expires 2031-02-16

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 16, 2021 Filed Feb 19, 2021 02:40 UTC
Kim Susan G.Chief Financial Officer
GrantCommon Stock 6,300 $0.00 $0.00
Disclosure

SEC source: 0001299130-21-000064 · certent-form4.xml · nonDerivative · entry 1

Kim Susan G. · CIK 0001825421 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,300

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 16 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 21:19 UTC
Shapiro LucyDirector
SaleCommon Stock 101,666 $50.40 $5,123,966.40
Disclosure

SEC source: 0001299130-21-000055 · certent-form4.xml · nonDerivative · entry 1

Shapiro Lucy · CIK 0001435944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $50.20 to $50.93 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:17 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001299130-21-000053 · certent-form4.xml · derivative · entry 7

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2023-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:17 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.83 $0.00
Disclosure

SEC source: 0001299130-21-000053 · certent-form4.xml · derivative · entry 6

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:17 UTC Exercise / conversionStock Option (right to buy) · Derivative 17,500 $0.00 Strike: $10.58 $0.00
Disclosure

SEC source: 0001299130-21-000053 · certent-form4.xml · derivative · entry 5

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires 2021-06-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:17 UTC SaleCommon Stock 67,500 $48.07 $3,244,455.00
Disclosure

SEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 4

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:17 UTC Exercise / conversionCommon Stock 25,000 $2.54 $63,500.00
Disclosure

SEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 3

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:17 UTC Exercise / conversionCommon Stock 25,000 $1.83 $45,750.00
Disclosure

SEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 2

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:17 UTC Exercise / conversionCommon Stock 17,500 $10.58 $185,150.00
Disclosure

SEC source: 0001299130-21-000053 · certent-form4.xml · nonDerivative · entry 1

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001299130-21-000051 · certent-form4.xml · derivative · entry 14

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $8.98 $0.00
Disclosure

SEC source: 0001299130-21-000051 · certent-form4.xml · derivative · entry 13

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2026-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $5.79 $0.00
Disclosure

SEC source: 0001299130-21-000051 · certent-form4.xml · derivative · entry 12

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2025-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $4.45 $0.00
Disclosure

SEC source: 0001299130-21-000051 · certent-form4.xml · derivative · entry 11

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2024-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001299130-21-000051 · certent-form4.xml · derivative · entry 10

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2023-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 35,000 $0.00 Strike: $1.93 $0.00
Disclosure

SEC source: 0001299130-21-000051 · certent-form4.xml · derivative · entry 9

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,000 shares

Expires 2021-07-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 12, 2021 Filed Feb 18, 2021 02:15 UTC SaleCommon Stock 5,142 $50.09 $257,567.92
Disclosure

SEC source: 0001299130-21-000051 · certent-form4.xml · nonDerivative · entry 8

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $50.08 to $50.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.